20-59019435-G-C
Position:
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBS1_SupportingBS2
The NM_030773.4(TUBB1):c.-88G>C variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.013 in 1,501,846 control chromosomes in the GnomAD database, including 183 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.0084 ( 8 hom., cov: 33)
Exomes 𝑓: 0.014 ( 175 hom. )
Consequence
TUBB1
NM_030773.4 5_prime_UTR_premature_start_codon_gain
NM_030773.4 5_prime_UTR_premature_start_codon_gain
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.317
Genes affected
TUBB1 (HGNC:16257): (tubulin beta 1 class VI) This gene encodes a member of the beta tubulin protein family. Beta tubulins are one of two core protein families (alpha and beta tubulins) that heterodimerize and assemble to form microtubules. This protein is specifically expressed in platelets and megakaryocytes and may be involved in proplatelet production and platelet release. A mutations in this gene is associated with autosomal dominant macrothrombocytopenia. Two pseudogenes of this gene are found on chromosome Y.[provided by RefSeq, Jul 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BS1
Variant frequency is greater than expected in population sas. gnomad4 allele frequency = 0.00836 (1274/152334) while in subpopulation SAS AF= 0.0205 (99/4824). AF 95% confidence interval is 0.0173. There are 8 homozygotes in gnomad4. There are 573 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High AC in GnomAd4 at 1274 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TUBB1 | NM_030773.4 | c.-88G>C | 5_prime_UTR_premature_start_codon_gain_variant | 1/4 | ENST00000217133.2 | NP_110400.1 | ||
TUBB1 | NM_030773.4 | c.-88G>C | 5_prime_UTR_variant | 1/4 | ENST00000217133.2 | NP_110400.1 | ||
TUBB1 | XM_017028085.2 | c.-10+2890G>C | intron_variant | XP_016883574.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TUBB1 | ENST00000217133 | c.-88G>C | 5_prime_UTR_premature_start_codon_gain_variant | 1/4 | 1 | NM_030773.4 | ENSP00000217133.1 | |||
TUBB1 | ENST00000217133 | c.-88G>C | 5_prime_UTR_variant | 1/4 | 1 | NM_030773.4 | ENSP00000217133.1 |
Frequencies
GnomAD3 genomes AF: 0.00837 AC: 1274AN: 152216Hom.: 8 Cov.: 33
GnomAD3 genomes
AF:
AC:
1274
AN:
152216
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0136 AC: 18302AN: 1349512Hom.: 175 Cov.: 20 AF XY: 0.0138 AC XY: 9384AN XY: 677650
GnomAD4 exome
AF:
AC:
18302
AN:
1349512
Hom.:
Cov.:
20
AF XY:
AC XY:
9384
AN XY:
677650
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00836 AC: 1274AN: 152334Hom.: 8 Cov.: 33 AF XY: 0.00769 AC XY: 573AN XY: 74480
GnomAD4 genome
AF:
AC:
1274
AN:
152334
Hom.:
Cov.:
33
AF XY:
AC XY:
573
AN XY:
74480
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
24
AN:
3478
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Macrothrombocytopenia, isolated, 1, autosomal dominant Uncertain:1
Uncertain significance, no assertion criteria provided | research | ISTH-SSC Genomics in Thrombosis and Hemostasis, KU Leuven, Center for Molecular and Vascular Biology | - | - - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at